Literature DB >> 24819967

LC-MS/MS detection of increased androstenedione levels in patients receiving danazol therapy.

Verena Gounden1, Diala El-Maouche, Brian R Stolze, Ranganath Muniyappa, Steven J Soldin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24819967      PMCID： PMC4225186          DOI： 10.1097/FTD.0000000000000086

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN： 0163-4356            Impact factor:   3.681


× No keyword cloud information.
  7 in total

1.  Danazol as first-line therapy for aplastic anemia.

Authors:  José Carlos Jaime-Pérez; Perla R Colunga-Pedraza; Cynthia D Gómez-Ramírez; César H Gutiérrez-Aguirre; Olga G Cantú-Rodríguez; Luz C Tarín-Arzaga; David Gómez-Almaguer
Journal:  Ann Hematol       Date:  2011-01-29       Impact factor: 3.673

Review 2.  Medical therapy of endometriosis.

Authors:  David L Olive
Journal:  Semin Reprod Med       Date:  2003-05       Impact factor: 1.303

3.  Measurement of serum testosterone in women; what should we do?

Authors:  John Kane; Jonathan Middle; Marion Cawood
Journal:  Ann Clin Biochem       Date:  2007-01       Impact factor: 2.057

Review 4.  Efficacy of danazol in hematologic disorders.

Authors:  Y S Ahn
Journal:  Acta Haematol       Date:  1990       Impact factor: 2.195

5.  Simultaneous determination of 12 steroids by isotope dilution liquid chromatography-photospray ionization tandem mass spectrometry.

Authors:  Tiedong Guo; Robert L Taylor; Ravinder J Singh; Steven J Soldin
Journal:  Clin Chim Acta       Date:  2006-04-03       Impact factor: 3.786

6.  Danazol suppresses the production of interleukin-1 beta and tumor necrosis factor by human monocytes.

Authors:  H Mori; M Nakagawa; N Itoh; K Wada; T Tamaya
Journal:  Am J Reprod Immunol       Date:  1990-10       Impact factor: 3.886

7.  Adrenal steroids in serum during danazol therapy, taking into account cross-reactions between danazol metabolites and serum androgens.

Authors:  K Murakami; T Nakagawa; G Yamashiro; K Araki; K Akasofu
Journal:  Endocr J       Date:  1993-12       Impact factor: 2.349
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.